期刊文献+

严重急性呼吸综合征冠状病毒刺突蛋白在酿酒酵母中的表达和纯化

Expression and purification of spike protein of severe acute respiratory syndrome coronavirus in Saccharomyces cerevisiae
原文传递
导出
摘要 目的构建重组表达质粒pYES6-S,诱导SARS冠状病毒刺突蛋白(spike protein)在酿酒酵母中的表达并纯化。方法反转录获得SARS冠状病毒DNA片段,PCR法获得刺突蛋白基因互相重叠的四部分片段,酶切连接成全长,在大肠埃希菌E.coli JM109中构建重组表达克隆pYES6- S,在酿酒酵母中诱导表达并纯化。结果重组克隆pYES6-S经酶切、测序鉴定确定,插入片段大小、方向、碱基匹配与预期一致,获得1个完整的刺突蛋白基因,表达产物纯化后,电泳鉴定,相对分子质量大小近110 000。结论成功克隆SARS冠状病毒刺突蛋白基因全长,并在酿酒酵母中诱导表达成功,有助于抗SARS分子疫苗的研究。 Objective To construct the recombinant plasmid pYES6-S and express and purify spike protein of severe acute respiratory syndrome(SARS) coronavirus in Saccharomyces cerevisiae. Methods DNA fragments of SARS coronavirus were obtained by reverse transcription. Four overlapped fragments of spike protein genes were amplified by polymerase chain reaction(PCR) and ligated into an integral spike protein gene by restriction enzyme digestion. The spike protein gene recombined with pYES6 and cloned into E. coll. The recombinant plasmid pYES6-S was induced and expressed in Saccharomyces cerevisiae(INVScl)by galactose. Results The recombinant plasmid pYES6-S was confirmed that inserted fragment was right in length, direction and base matching by restriction enzyme digestion and sequencing. The purified protein encoded by the whole spike protein gene was about Mr 110× 10^3 identified by electrophoresis. Conclusion The whole spike protein gene of SARS coronavirus is cloned into E. coli and the protein is expressed in Saccharomyces cerevisiae successfully, which can be helpful in SARS vaccine research.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2007年第9期543-546,共4页 Chinese Journal of Infectious Diseases
基金 浙江省教育厅资助项目(20041044)
关键词 SARS病毒 刺突蛋白 反转录聚合酶链反应 克隆 分子 基因表达 酵母 酿酒 SARS virus Spike protein Reverse transcriptase polymerase chain reaction doning, molecular Gene expression Saccharomyces cerevisiae
  • 相关文献

参考文献10

  • 1Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 2003, 300:1394 -1399.
  • 2Marra MA, Jones SJ, Astell CR, et al. The Genome sequence of the SARS-associated coronavirus. Science, 2003, 300:1399- 1404.
  • 3Gao W, Tamin A, Soloff A, et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet, 2003, 362:1895-1896.
  • 4Yang ZY, Kong WP, Huang Y, et al. A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature, 2004, 428:561- 564.
  • 5Li W, Moore MJ, Vasilieva N, et al. Angiotensin converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature, 200a, 426:450-454.
  • 6Wang P, Chen J, Zheng A, et al. Expression cloning of functional receptor used by SARS coronavirus. Biochem Biophys Res Commun, 2004, 315 : 439-444.
  • 7Thoren PE, Persson D, Isakson P, et al. Uptake of analogs of penetratin, Tat (48 -60) and oligoarginine in live cells. Biochem Biophys Res Commun, 2003, 307 : 100-107.
  • 8Fischer R, Kohler K, Fotin Mleezek M, et al. A stepwise disseclion of the intracellular fate of cationic cell-penetrating peptides. J BiolChem, 2004, 279 :12625-12635.
  • 9Bisht H, Roberts A, Vogel L, et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA, 2004, 101:6641-6646.
  • 10Krueger DK, Kelly SM, Lewicki DN, et al. Variations in disparate regions of the routine coronavirus spike protein impact the initiation of membrane fusion. J Virol, 2001, 75:2792 2802.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部